2796 Stock Overview
Manages dispensing pharmacies in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Pharmarise Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥529.00 |
| 52 Week High | JP¥722.00 |
| 52 Week Low | JP¥520.00 |
| Beta | 0.17 |
| 1 Month Change | -12.42% |
| 3 Month Change | -16.43% |
| 1 Year Change | -19.85% |
| 3 Year Change | -28.99% |
| 5 Year Change | -17.73% |
| Change since IPO | 4.18% |
Recent News & Updates
Shareholder Returns
| 2796 | JP Consumer Retailing | JP Market | |
|---|---|---|---|
| 7D | -4.2% | 2.1% | 3.6% |
| 1Y | -19.8% | 9.0% | 16.3% |
Return vs Industry: 2796 underperformed the JP Consumer Retailing industry which returned 9% over the past year.
Return vs Market: 2796 underperformed the JP Market which returned 16.3% over the past year.
Price Volatility
| 2796 volatility | |
|---|---|
| 2796 Average Weekly Movement | 2.2% |
| Consumer Retailing Industry Average Movement | 2.9% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.2% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 2796 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 2796's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 1,848 | Masayuki Akiyama | www.pharmarise.com |
Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores.
Pharmarise Holdings Corporation Fundamentals Summary
| 2796 fundamental statistics | |
|---|---|
| Market cap | JP¥5.95b |
| Earnings (TTM) | -JP¥737.00m |
| Revenue (TTM) | JP¥58.06b |
0.1x
P/S Ratio-8.1x
P/E RatioIs 2796 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2796 income statement (TTM) | |
|---|---|
| Revenue | JP¥58.06b |
| Cost of Revenue | JP¥49.65b |
| Gross Profit | JP¥8.42b |
| Other Expenses | JP¥9.15b |
| Earnings | -JP¥737.00m |
Last Reported Earnings
Nov 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -65.55 |
| Gross Margin | 14.50% |
| Net Profit Margin | -1.27% |
| Debt/Equity Ratio | 192.4% |
How did 2796 perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield-22%
Payout RatioDoes 2796 pay a reliable dividends?
See 2796 dividend history and benchmarks| Pharmarise Holdings dividend dates | |
|---|---|
| Ex Dividend Date | May 29 2025 |
| Dividend Pay Date | Sep 01 2025 |
| Days until Ex dividend | 149 days |
| Days until Dividend pay date | 244 days |
Does 2796 pay a reliable dividends?
See 2796 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 03:34 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/11/30 |
| Annual Earnings | 2024/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pharmarise Holdings Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|